Drug Tracker: clinical trial management

Clinical Trial Management System is a software system used by the biotechnology and pharmaceutical industries to manage clinical trials in clinical research. This system maintains and manages performance, planning, and reporting functions, along with relevant participant information such as contact information, follow-up deadlines, and milestones.

The system is comprised of protocol development, site selection and trial preparation, subject identification and enrollment, data collection, monitoring, and processing, data analysis and reporting, pharmacovigilance, and submission for review. Data is collected during the testing process and stored in the database. The data is then reviewed to decide on the safety parameter of the drug.

How is clinical trial management useful?

· Insights in real time of the operations: It is a system that provides a central place to record the operational activity, which offers easy access to important information.

Stronger Financial Management – ​​Supports budgeting consistency across the enterprise and provides access to all financial information.

Increased staff efficiency – Reduces duplicate data entry and therefore only relevant information is present in the software. This saves staff time and increases data accuracy and consistency.

They are experiments carried out in clinical research to determine drugs or procedures that will or will not benefit the patient. Chronic heart disease, cancer, diabetes, stroke, and arthritis have long-lasting effects that persist for more than three months after treatment. Globally, chronic diseases kill more than 38 million people each year. Cardiovascular diseases account for the majority of deaths, approximately 17.5 million people a year, followed by cancer (8.2 million), respiratory diseases (4 million) and diabetes (1.5 million). These four groups account for 82% of deaths from chronic diseases. New drugs and procedures need to be developed to deal with these diseases. In addition to this, communicable diseases, such as Ebola, swine flu, etc. they still do not have effective cures. Due to all these factors, the number of clinical trials conducted has increased significantly in the last decade.

A report by a market research firm estimates a double-digit growth rate for the clinical trial management market

Increased incidence of chronic disease, increased R&D to implement localized research programs, increased outsourcing of clinical research and implementation of clinical trials by contract research organizations, and synchronization of Hospital Information System (HIS) with CTMS are some of the factors driving the growth of the market.

Barriers to the market: Data security issues, the lack of skilled and skilled manpower to handle CTMS, the increasing failure rate of clinical trials in Phase II and Phase III, and the high cost of custom CTMS are some of the factors hindering market growth.

Far ahead: The future implies the development of advanced software with high precision and efficiency, which is likely to provide lucrative opportunities for market growth.